Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?

Cherri, Sara; Noventa, Silvia; Zaniboni, Alberto

Cherri, Sara; Noventa, Silvia; Zaniboni, Alberto.

Cherri S; Department of Oncology, Fondazione Poliambulanza, Brescia, Italy. Electronic address: sara.m.cherri@gmail.com.
Noventa S; Department of Oncology, Fondazione Poliambulanza, Brescia, Italy.
Zaniboni A; Department of Oncology, Fondazione Poliambulanza, Brescia, Italy.

Med Hypotheses ; 141: 109758, 2020 Aug.

Article in English | MEDLINE | ID: covidwho-102062

Subject(s)

COVID-19; Communicable Diseases; Cytokines; Humans; Inflammation; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google